Kite Pharma, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Kite Pharma, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$52.68 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-08-08
- Kite Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$34.88M.
- Kite Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$17.81M.
- Kite Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was -$49.21M.
- Kite Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was -$36.62M.
- Kite Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$16.09M.
- Kite Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$17.07M.
- Kite Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$5.61M.
- Kite Pharma, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was -$2.79M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|---|
| 2017-06-30 | -$34.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$52.68M 10-Q · filed 2017-08-08 | |||||
| 2017-03-31 | -$17.81M 10-Q · filed 2017-05-08 | ||||||
| 2016-09-30 | -$49.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$85.83M derived: sum of 2 quarters · filed 2017-08-08 | -$114.99M 10-Q · filed 2016-11-09 | -$136.83M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2016-06-30 | -$36.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$65.78M 10-Q · filed 2017-08-08 | -$64.94M 10-Q · filed 2016-08-08 | -$87.62M derived: sum of 3 quarters · filed 2017-08-08 | -$104.55M derived: sum of 4 quarters · filed 2017-08-08 | ||
| 2016-03-31 | -$29.17M 10-Q · filed 2017-05-08 | -$28.69M 10-Q · filed 2016-05-09 | -$51.00M derived: sum of 2 quarters · filed 2017-05-08 | -$67.94M derived: sum of 3 quarters · filed 2017-05-08 | -$98.28M derived: sum of 4 quarters · filed 2017-05-08 | ||
| 2015-12-31 | -$21.84M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$38.77M derived: sum of 2 quarters · filed 2016-11-09 | -$69.12M derived: sum of 3 quarters · filed 2016-11-09 | -$16.09M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | -$16.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$47.28M derived: sum of 2 quarters · filed 2016-11-09 | $5.75M 10-Q · filed 2016-11-09 | $6.89M 10-Q · filed 2015-11-12 | $1.09M derived: sum of 4 quarters · filed 2016-11-09 | ||
| 2015-06-30 | -$30.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $22.68M 10-Q · filed 2016-08-08 | $24.39M 10-Q · filed 2015-08-10 | $18.03M derived: sum of 3 quarters · filed 2016-08-08 | $12.17M derived: sum of 4 quarters · filed 2016-08-08 | ||
| 2015-03-31 | $53.03M 10-Q · filed 2016-05-09 | $53.08M 10-Q · filed 2015-05-15 | $48.38M derived: sum of 2 quarters · filed 2016-05-09 | $42.52M derived: sum of 3 quarters · filed 2016-05-09 | $39.08M derived: sum of 4 quarters · filed 2016-05-09 | ||
| 2014-12-31 | -$4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$10.51M derived: sum of 2 quarters · filed 2016-02-29 | -$13.95M derived: sum of 3 quarters · filed 2016-02-29 | -$17.07M 10-K · filed 2016-02-29 | |||
| 2014-09-30 | -$5.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$9.29M derived: sum of 2 quarters · filed 2015-11-12 | -$12.42M 10-Q · filed 2015-11-12 | -$14.02M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | -$3.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$6.56M 10-Q · filed 2015-08-10 | -$8.15M derived: sum of 3 quarters · filed 2016-02-29 | -$9.85M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$3.12M 10-Q · filed 2015-05-15 | -$4.72M derived: sum of 2 quarters · filed 2016-02-29 | -$6.42M derived: sum of 3 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$3.29M derived: sum of 2 quarters · filed 2016-02-29 | -$5.61M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$4.01M 10-Q · filed 2014-11-14 | |||||
| 2013-06-30 | -$2.32M 10-Q · filed 2014-08-14 | ||||||
| 2012-12-31 | -$2.79M 10-K · filed 2015-03-26 |